| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Whitefort Capital Management, LP | Arbutus Biopharma Corp | 13,197,062 | 7.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Two Seas Capital LP | Arbutus Biopharma Corp | 9,041,927 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-12 | BlackRock Inc. | Arbutus Biopharma Corp | 10,390,300 | 6.2% | EDGAR |
| SC 13G | 2023-11-21 | Two Seas Capital LP | Arbutus Biopharma Corp | 9,503,103 | 5.7% | EDGAR |
| SC 13G | 2023-09-11 | Whitefort Capital Management, LP | Arbutus Biopharma Corp | 10,013,899 | 6.0% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Arbutus Biopharma Corp | 8,700,392 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | Arbutus Biopharma Corp | 2,504,493 | 1.7% | EDGAR |
| SC 13D/A | 2021-10-20 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 38,847,462 | 29.1% | EDGAR |
| SC 13G/A | 2021-02-16 | Foresite Capital Fund IV, L.P. | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | RTW INVESTMENTS, LP | Arbutus Biopharma Corp | 5,978,355 | 7.0% | EDGAR |
| SC 13G/A | 2021-02-10 | MORGAN STANLEY | Arbutus Biopharma Corp | 1,438,264 | 1.7% | EDGAR |
| SC 13G | 2020-07-16 | MORGAN STANLEY | Arbutus Biopharma Corp | 3,497,578 | 5.1% | EDGAR |
| SC 13G/A | 2020-02-14 | EcoR1 Capital, LLC | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Foresite Capital Fund IV, L.P. | Arbutus Biopharma Corp | 3,705,128 | 6.5% | EDGAR |
| SC 13G/A | 2020-02-14 | RTW INVESTMENTS, LP | Arbutus Biopharma Corp | 5,666,754 | 9.1% | EDGAR |
| SC 13G | 2019-12-09 | Foresite Capital Fund IV, L.P. | Arbutus Biopharma Corp | 3,205,128 | 5.6% | EDGAR |
| SC 13G | 2019-11-05 | PRIMECAP MANAGEMENT CO/CA/ | Arbutus Biopharma Corp | 600,000 | 1.1% | EDGAR |
| SC 13D/A | 2019-07-17 | Machado Patrick | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-17 | Lo Andrew | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-16 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 28.2% | EDGAR |